{{Drugbox
| Watchedfields = changed
| verifiedrevid = 461102463
| IUPAC_name = (''RS'')-2-(2-fluorobiphenyl-4-yl)propanoic acid
| image = Flurbiprofen.svg
| width =
| chirality = [[Racemic mixture]]
<!--Clinical data-->
| tradename = Ansaid, Ocufen, Strepfen
| Drugs.com = {{drugs.com|monograph|flurbiprofen}}
| MedlinePlus = a687005
| pregnancy_AU = B2
| pregnancy_US = C
| pregnancy_category =
| legal_status = <!-- POD - what is POD? -->
| routes_of_administration = Oral
<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound = > 99%
| metabolism = [[Liver|Hepatic]] ([[CYP2C9]])
| elimination_half-life = 4.7-5.7 hours
| excretion = [[Kidney|Renal]]
<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 5104-49-4
| ATC_prefix = M01
| ATC_suffix = AE09
| ATC_supplemental =, {{ATC|M02|AA19}}, {{ATC|R02|AX01}}, {{ATC|S01|BC04}}
| PubChem = 3394
| IUPHAR_ligand = 4194
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00712
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 3277
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 5GRO578KLP
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00330
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 5130
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 563
| PDB_ligand = FLP
<!--Chemical data-->
| C=15 | H=13 | F=1 | O=2
| molecular_weight = 244.261 g/mol
| SMILES = Fc2cc(ccc2c1ccccc1)C(C(=O)O)C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C15H13FO2/c1-10(15(17)18)12-7-8-13(14(16)9-12)11-5-3-2-4-6-11/h2-10H,1H3,(H,17,18)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = SYTBZMRGLBWNTM-UHFFFAOYSA-N
| synonyms = <small>(±)-2-fluoro-α-methyl-(1,1'-biphenyl)-4-acetic acid</small>
| melting_point = 117
}}

'''Flurbiprofen''' is a member of the [[phenylalkanoic acid]] derivative family of [[nonsteroidal anti-inflammatory drug]]s (NSAIDs). It is primarily indicated as a pre-operative [[miosis|anti-miotic]] (in an [[eye drop|ophthalmic solution]]) as well as orally for [[arthritis]] or dental pain. Side effects are analogous to those of ibuprofen.<ref>{{cite web|title=Lexicomp: Flurbiprofen|url=http://online.lexi.com/lco/action/doc/retrieve/docid/patch_f/1797302|website=Lexicomp|publisher=Wolters Kluwer|accessdate=25 September 2015}}</ref> 

It was derived from [[propionic acid]] by the research arm of [[Boots UK]] during the 1960s, a period which also included the discovery of [[ibuprofen]], [[indometacin]], [[diclofenac]], [[naproxen]], [[ketoprofen]], and [[sulindac]].<ref name = plat12>{{cite journal|last1=Halford|first1=GM|last2=Lordkipanidzé|first2=M|last3=Watson|first3=SP|title=50th anniversary of the discovery of ibuprofen: an interview with Dr Stewart Adams.|journal=Platelets|date=2012|volume=23|issue=6|pages=415–22|doi=10.3109/09537104.2011.632032|pmid=22098129}}</ref><ref>Rainsford KD. [http://paperity.org/p/6515758/fifty-years-since-the-discovery-of-ibuprofen Fifty years since the discovery of ibuprofen]. Inflammopharmacology. 2011 Dec;19(6):293-7. {{PMID|22120888}}</ref><ref>Janos Fischer and C. Robin Ganellin. Analogue-based Drug Discovery II.  John Wiley & Sons, 2010 {{ISBN|9783527632121}}</ref>{{rp|34}}

Pharmacia & Upjohn developed the drug in the US and it received FDA approval in 1988; the first [[generic drug|generic]] was approved in 1994.<ref>{{cite book|title=Approved Drug Products with Therapeutic Equivalence Evaluations|date=2014|publisher=FDA|edition=36th|url=http://www.nber.org/fda/orange-book/pdf/UCM071436.pdf}}</ref>{{rp|158}}

As of 2016 the drug was available worldwide as drops for ophthalmic use and as tablets, both in various strengths, under many brand names which include: Acustop Cataplasma, Adofeed, Anazin, Anflupin, Anorcid, Ansaid, Antadys, Antafen, Antipain, Baenazin, Benactiv, Biprofin, Biprotec, Bro-Z, Brufen, Brufoz, Cebutid, Clinadol, Coryfin, Dispain, Edolfene, Eyeflur, Falken, Fiera, Flu Ro Fen, Flubifix, Flufen, Flugalin, Flupe, Flur di fen, Fluractive, Fluran, Flurbi Pap, Flurbic, Flurbiprofen, Flurbiprofène, Flurbiprofeno, Flurflex, Flurofen, Fluroptic, Fo Bi Pu Luo Fun, Forphen, Fortine, Froben, Frolix, Fubifen, Fubiprofen, Fubofen, Fukon, Fulruban, Furofen, Kai Fen, Kavoflog, Kotton, Lefenine, Majezik, Maprofen, Maxaljin, Maximus, Meiprofen, Neliacan, Nibelon, Nirolex Gola, Ocufen, Ocuflur, Optifen, Orofaringeo, Painil, Profen, Projezik, Ropion, Sigmaprofen, Stayban, Strefen, Strepfen, Strepflam, Strepsils (various formulations), Sulan, Tie Shr Shu, TransAct, Upnon, Urbifen, Yakuban, Zepolas, Zeralgo, Zero-P, and Zeton.<ref>{{cite web|title=Flurbiprofen - International Brand Names|url=https://www.drugs.com/international/flurbiprofen.html|publisher=Drugs.com|accessdate=14 November 2016}}</ref>

As of 2015 the cost for a typical month of medication in the United States is 50 to 100 USD.<ref name=Ric2015>{{cite book|last1=Hamilton|first1=Richart|title=Tarascon Pocket Pharmacopoeia 2015 Deluxe Lab-Coat Edition|date=2015|publisher=Jones & Bartlett Learning|isbn=9781284057560|page=8}}</ref>

==References==
{{reflist}}

{{Anti-inflammatory and antirheumatic products}}
{{Topical products for joint and muscular pain}}
{{Analgesics}}
{{Throat preparations}}
{{Prostanoidergics}}

[[Category:Nonsteroidal anti-inflammatory drugs]]
[[Category:Fluoroarenes]]
[[Category:Phenyl alkanoic acids]]
[[Category:Propionic acids]]


{{respiratory-system-drug-stub}}
{{musculoskeletal-drug-stub}}
{{analgesic-stub}}